Endotoxin neutralization as a biomonitor for inflammatory bowel disease

Area of Science:

• Immunology
• Microbiology
• Clinical Diagnostics

Background:

• Gram-negative bacterial endotoxin acts as a potent immunostimulant, contributing to various disease pathologies.
• The mammalian immune system employs both innate and adaptive responses to neutralize endotoxin.
• Existing methods lack comprehensive monitoring of endotoxin exposure and immune response dynamics.

Purpose of the Study:

• To develop and validate a system for monitoring bacterial exposure by quantifying endotoxin neutralization in plasma.
• To investigate sex-based differences in endotoxin neutralization capacity.
• To characterize the innate and adaptive immune responses to endotoxin in patients with inflammatory bowel disease (IBD).

Main Methods:

• Development of a plasma-based assay to measure the extent and nature of endotoxin neutralization.
• Utilized inactivation techniques to differentiate early (innate) and late (adaptive) immune responses.
• Applied the developed system to analyze plasma samples from control individuals and IBD patients.

Main Results:

• Females exhibited higher endotoxin neutralization levels than males in control subjects, correlating with clinical observations in bacterial infections and sepsis.
• IBD patients demonstrated a more robust overall endotoxin neutralization response compared to controls.
• The immune response in IBD patients was characterized by a greater reliance on adaptive immunity and less on innate immunity.

Conclusions:

• Endotoxin neutralization measurement is a valuable biomarker for differentiating IBD patients from healthy controls.
• The specific nature of endotoxin neutralization provides insights into disease severity and potential therapeutic monitoring.
• The developed system offers a novel approach to assess immune system dynamics in response to bacterial endotoxin.